What is KLOW?
KLOW is a blend of four research peptides co-lyophilized in a single vial: GHK-Cu, BPC-157, TB-500 and KPV, 80mg in total. It is supplied for laboratory work that calls for the four materials together in fixed proportion. KLOW is a catalog name for the blend, not a single compound.
KLOW composition
Each vial contains GHK-Cu 50mg, a copper(II) complex of the tripeptide Gly-His-Lys; BPC-157 10mg, a 15 residue linear peptide; TB-500 10mg, the acetylated seven residue fragment Ac-LKKTETQ; and KPV 10mg, the tripeptide Lys-Pro-Val. The copper complex gives the blend its blue to blue green color. Because the four components sit in one vial, each is resolved separately on the chromatogram and confirmed separately by mass.
Where this material appears in the literature
There is no dedicated literature on this blend as a single material. Each component appears individually in preclinical and in vitro work: GHK-Cu in studies of copper peptide chemistry and extracellular matrix models, BPC-157 and TB-500 in soft tissue models, and KPV as a short C-terminal fragment of alpha-MSH in in vitro inflammation pathway studies. Imperial Biolab supplies the material for that kind of laboratory investigation and makes no claim about what it does in any living subject.
Related material in the catalog
Two of the four components are also available as single compounds: BPC-157 and TB-500. Single compound vials are the better choice where a study needs each material at an independently chosen ratio.
Analysis and certification
Every batch is analyzed by an independent, accredited US laboratory before release, using RP-HPLC for purity and LC-MS for identity confirmation. The certificate of analysis is published against the batch number rather than against the product page, so the document you read is the document for the vial you receive. The batch number printed on the vial label, and the QR code beside it, are the link between the two.
Purity specification
Batches are released against a ≥99% purity specification, determined by RP-HPLC peak area. A specification is a release threshold, not a description of every batch. The measured figure for the batch you receive is stated on its certificate of analysis and may sit above the specification.
Where a measured figure and the specification differ, the certificate is the record that applies to your material. Analytical figures relate to the batch they are published against and carry no implication of suitability for any purpose beyond laboratory research.
Research use only
Imperial Biolab supplies this material as a reference standard for in vitro laboratory research. It is not supplied for any use in humans or animals, it is not a drug, dietary supplement, food or cosmetic, it has not been evaluated by the FDA, and nothing on this page describes or implies any such use. Sale is restricted to persons aged 21 or over who are qualified researchers or who purchase on behalf of a research institution, laboratory or business.
| Product |
KLOW research blend |
| Class |
Co-lyophilized peptide blend |
| Components |
GHK-Cu 50mg; BPC-157 10mg; TB-500 10mg; KPV 10mg |
| GHK-Cu |
Gly-His-Lys copper(II) complex |
| BPC-157 |
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, 1419.54 Da |
| TB-500 |
Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln, 889.0 Da |
| KPV |
Lys-Pro-Val, 342.4 Da |
| Appearance |
Blue to blue green lyophilized powder |
| Purity specification |
≥99% |
| Purity method |
RP-HPLC |
| Identity method |
LC-MS |
| Solubility |
Soluble in sterile water and aqueous buffers for analytical preparation |
| Labeled quantity |
80mg per vial (GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg, KPV 10mg) |
Characterization. Values above describe the compound as supplied. The figures for the batch you receive, including measured purity, are stated on its certificate of analysis.
How this material is tested
Two separate analyses are carried out on every batch before release, and both appear on the certificate.
- RP-HPLC, for purity. Reversed phase high performance liquid chromatography separates the material by hydrophobicity. The main peak is integrated against total peak area, and that ratio is the purity figure reported on the certificate.
- LC-MS, for identity. Liquid chromatography coupled to mass spectrometry confirms that the mass of the main peak matches the expected mass for the compound, component by component, so each of the four peptides in the vial is individually identified.
A complete certificate carries the compound name, the batch number, the test date, the method, the measured purity and the name of the laboratory. If any of those is missing, or the batch number on the vial does not match the certificate, contact us before using the material.
Storing KLOW
Stock is held at −20°C until picking and ships in insulated packaging. Move the vial into freezer storage on arrival and keep it sealed, dry, at −20°C or below, protected from light and moisture. The copper complex is sensitive to light, so keep the vial in its outer packaging or in the dark. Returned promptly to those conditions, the dry solid is the most stable form this material takes.
Preparing stock solutions
Prepare stock solutions in sterile water or an appropriate aqueous buffer at a concentration suited to your assay, expressed in mg/mL. Allow the vial to reach room temperature before opening, add solvent down the vial wall rather than directly onto the solid, and let the material dissolve without vigorous agitation. All four components dissolve in water, and the solution takes on the blue tint of the copper complex. Note that every stock prepared from this vial contains all four components in the labeled ratio.
Solutions are less stable than the lyophilized solid. Prepare close to the point of use, hold at 2 to 8°C for short periods only, and aliquot before freezing so that repeated freeze and thaw cycles are avoided.
On arrival
Check that the vial is intact and sealed, that the compound name and labeled quantity match your order, and that the batch number on the label matches the certificate published for it. If anything does not match, or the packaging has clearly failed in transit, contact us before using the material. Problems visible on arrival should be reported within 7 days of delivery, with photos of the packaging and the batch label, so that a carrier claim remains possible.
Handling and disposal
Assess the hazards of this material before handling it and use appropriate controls and protective equipment. It has not been characterized toxicologically and should be treated as potentially hazardous. Anyone handling it should be trained for the work.
Dispose of unused material, vials and packaging lawfully and in line with your institution's waste procedures.
Record keeping
Record the batch number in your notes at the point of first use, alongside the date the vial was opened and the concentration of any stock prepared. Certificates are published against the batch number rather than the product, so the batch number is the only reliable link between your results and the analytical data for the material that produced them. If a question arises about a result months later, that link is what keeps the work auditable.